Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect-Reference-Cited by-同舟云学术

Pegylated liposomal mitoxantrone is more therapeutically active than mitoxantrone in L1210 ascitic tumor and exhibits dose-dependent activity saturation effect

Published:2014-01 Issue:1-2 Volume:460 Page:165-172
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Li ChunLei,Zhao Xi,Deng ChenXin,Wang CaiXia,Wei Na,Cui JingXia

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference26 articles.

1. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity;Adlakha-Hutcheon;Nat. Biotechnol.,1999

2. Separation of liposome-entrapped mitoxantrone from nonliposomal mitoxantrone in plasma: pharmacokinetics in mice;Ahmad;Method. Enzymol.,2005

3. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2;Cabanes;Clin. Cancer Res.,1999

4. Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice;Chang;Brit. J. Cancer,1997

5. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?;Cui;J. Control. Release,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Liposomal Co-delivery of an Immunogenic Cell Death Inducer and a Toll-Like Receptor 4 Agonist for Enhanced Cancer Chemo-immunotherapy;ACS Applied Materials & Interfaces;2024-07-31

2. Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer;European Journal of Clinical Pharmacology;2024-06-21

3. Liposomal mitoxantrone-based multidrug chemotherapy as a bridge to allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute lymphoblastic leukemia (ALL) after immunotherapy failure: a case report;Frontiers in Medicine;2024-05-22

4. A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone;Biomaterials;2023-02

5. The Applications of Mitoxantrone and Its Liposome in Adult Acute Myeloid Leukemia;Open Journal of Blood Diseases;2023